Crossmark

Improving combination drug trials using ‘definitive screening designs’

Crossref DOI link: https://doi.org/10.1038/s41587-022-01521-w

Published Online: 2022-11-18

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dodds, Michael https://orcid.org/0000-0002-0135-7840
Roberts, James https://orcid.org/0000-0003-3919-6760
Finrow, Brian https://orcid.org/0000-0001-7527-9307
License Information

Text and Data Mining valid from 2022-11-18

Version of Record valid from 2022-11-18
More Information

Article History

First Online: 18 November 2022

Competing interests

: The authors are employees of Lumen Bioscience.